Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Regen BioPharma (RGBPP) Long-Term Investments (2024 - 2025)

Regen BioPharma (RGBPP) has disclosed Long-Term Investments for 2 consecutive years, with $17733.0 as the latest value for Q2 2025.

  • On a quarterly basis, Long-Term Investments changed N/A to $17733.0 in Q2 2025 year-over-year; TTM through Jun 2025 was $17733.0, a N/A change, with the full-year FY2024 number at $17733.0, changed N/A from a year prior.
  • Long-Term Investments was $17733.0 for Q2 2025 at Regen BioPharma, roughly flat from $17733.0 in the prior quarter.
  • In the past five years, Long-Term Investments ranged from a high of $17733.0 in Q3 2024 to a low of $17733.0 in Q3 2024.